mounjaro tirzepatide reviews New Trial Results Position for FDA Weight Loss Drug Approval Mounjaro: Indications for Use, Doses

Peak results, including significant weight loss, are typically observed between four and six months, with the most dramatic changes happening during the early months

A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with overweight or obesity and knee osteoarthritis, according to topline results from the TRIUMPH-4 trial

Recently, there has been a lot of talk about using semaglutide with B12 injections

Generally mild, but it is a new signal

Dr John Patterson, a GP in Oldham and clinical adviser to NICE, shares his insights on the latest in a new generation of weight loss medicines:

Then the FDA killed compounded semaglutide, and the drugmakers went direct